|
Market Closed -
Swiss Exchange
11:30:53 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 53.30 CHF | -0.04% |
|
-0.67% | -15.77% |
| 09-24 | Bernstein: Alcon a 'Top Long-term Compounder' Amid 'Transitory' Near-term Pressures | MT |
| 09-11 | Berenberg Sees Alcon as 'Best Way' into Ophthalmology Market Exposure; Buy Rating Affirmed | MT |
Company Valuation: Alcon Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 43,286 | 33,596 | 38,446 | 41,934 | 39,316 | 31,089 | - | - |
| Change | - | -22.39% | 14.43% | 9.07% | -6.24% | -20.93% | - | - |
| Enterprise Value (EV) 1 | 46,197 | 37,296 | 42,046 | 44,734 | 42,526 | 33,664 | 32,574 | 31,117 |
| Change | - | -19.27% | 12.73% | 6.39% | -4.93% | -20.84% | -3.24% | -4.47% |
| P/E | 116x | 100x | 39.8x | 41.4x | 40.4x | 37.3x | 22.9x | 19.2x |
| PBR | 2.25x | 1.71x | 1.86x | 1.94x | 1.79x | 1.44x | 1.37x | 1.28x |
| PEG | - | -9.5x | 0x | 9.02x | -11.83x | -2.9x | 0.4x | 1x |
| Capitalization / Revenue | 5.22x | 3.85x | 4.07x | 4.23x | 3.78x | 2.8x | 2.64x | 2.48x |
| EV / Revenue | 5.57x | 4.28x | 4.45x | 4.51x | 4.09x | 3.04x | 2.77x | 2.49x |
| EV / EBITDA | 25.7x | 20.8x | 18.1x | 17.9x | 15.9x | 11.4x | 10x | 8.72x |
| EV / EBIT | 32x | 23.7x | 22.7x | 22.1x | 20.9x | 14.4x | 12.6x | 10.8x |
| EV / FCF | 71.6x | 64.2x | 57.6x | 27.9x | 24.5x | 22.4x | 18.6x | 16x |
| FCF Yield | 1.4% | 1.56% | 1.74% | 3.59% | 4.08% | 4.46% | 5.37% | 6.26% |
| Dividend per Share 2 | 0.2159 | 0.2239 | 0.273 | 0.3138 | 0.362 | 0.3716 | 0.4155 | 0.4714 |
| Rate of return | 0.24% | 0.33% | 0.35% | 0.37% | 0.45% | 0.58% | 0.65% | 0.73% |
| EPS 2 | 0.76 | 0.68 | 1.96 | 2.05 | 1.98 | 1.724 | 2.809 | 3.353 |
| Distribution rate | 28.4% | 32.9% | 13.9% | 15.3% | 18.3% | 21.5% | 14.8% | 14.1% |
| Net sales 1 | 8,291 | 8,717 | 9,455 | 9,911 | 10,401 | 11,087 | 11,769 | 12,517 |
| EBITDA 1 | 1,799 | 1,795 | 2,325 | 2,502 | 2,677 | 2,963 | 3,253 | 3,567 |
| EBIT 1 | 1,443 | 1,571 | 1,849 | 2,027 | 2,039 | 2,337 | 2,588 | 2,871 |
| Net income 1 | 376 | 335 | 974 | 1,018 | 980 | 792.6 | 1,332 | 1,625 |
| Net Debt 1 | 2,911 | 3,700 | 3,600 | 2,800 | 3,210 | 2,575 | 1,485 | 27.77 |
| Reference price 2 | 88.32 | 68.33 | 77.95 | 84.78 | 80.04 | 64.31 | 64.31 | 64.31 |
| Nbr of stocks (in thousands) | 490,100 | 491,700 | 493,200 | 494,600 | 491,200 | 483,400 | - | - |
| Announcement Date | 2/15/22 | 2/27/23 | 2/27/24 | 2/25/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 37.3x | 3.04x | 11.36x | 0.58% | 31.09B | |
| 24.63x | 2.51x | 10.09x | 2.84% | 75.37B | |
| 131.98x | 10.08x | 48.15x | -.--% | 12.34B | |
| 16.29x | 3.06x | 9.81x | -.--% | 10.53B | |
| 23.62x | 5.83x | 17.04x | 1.17% | 2.37B | |
| 20.38x | 3.85x | 10.99x | 1.72% | 1.35B | |
| 15.27x | 3.17x | 8.16x | 2.8% | 972M | |
| -10.67x | - | - | - | 905M | |
| 26.86x | - | - | - | 899M | |
| 18.9x | 1.32x | 7.65x | 1.65% | 832M | |
| Average | 30.45x | 4.11x | 15.41x | 1.35% | 13.66B | |
| Weighted average by Cap. | 36.18x | 3.43x | 13.95x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALC Stock
- Valuation Alcon Inc.
Select your edition
All financial news and data tailored to specific country editions
